In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma.
Saved in:
| Title: | In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma. |
|---|---|
| Authors: | Liang JD; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Liang PC; Department of Medical Imaging and Radiology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Medical Imaging, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan., Shun CT; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan., Chen CH; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan., Wu YM; Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Surgical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Hsu YC; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan.; Department of Clinical Laboratory Science and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan., Lee YT; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan., Yang PM; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan., Huang GT; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan., Salazar AM; Oncovir, Washington, DC, USA., Lee HS; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan., Sheu JC; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Liver Disease Prevention and Treatment Research Foundation, Taipei, Taiwan., Weng MT; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan. |
| Source: | Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2025 Jun 14; Vol. 12, pp. 1191-1204. Date of Electronic Publication: 2025 Jun 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Country of Publication: New Zealand NLM ID: 101674775 Publication Model: eCollection Cited Medium: Print ISSN: 2253-5969 (Print) Linking ISSN: 22535969 NLM ISO Abbreviation: J Hepatocell Carcinoma Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2253-5969 |
|---|---|
| DOI: | 10.2147/JHC.S520710 |
